MedDataX Logo

Dose Response of Pursed Lip Breathing With Diaphragmatic Breathing On Pulmonary Functions in Patients With COPD

NCT ID: NCT04928729

Last Updated: 2021-10-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-15

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

1. To determine the Effects of combined pursed lip breathing with diaphragmatic breathing on pulmonary functions in patient with COPD.
2. To determine the different durations of combined pursed lip breathing with diaphragmatic breathing on Pulmonary functions in patient with COPD.
3. To determine the Effects of combined pursed lip breathing with diaphragmatic breathing on quality of life in patient with COPD

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The technique of pursed lip breathing allow the patients to control the oxygenation and ventilation. This technique is performed by allowing the person to inspire through the nose exhale through the mouth at a slow controlled flow. This technique works by moving oxygen into your lungs and carbon dioxide out of your lungs. Pursed lip breathing (PLB) helps to slow down breathing rate and relieving shortness of breath by keeping the airways open longer. So patients can remove the air that is trapped in to the lungs.

In a recent systematic review that is published in 2018, PLB was shown to significantly improve ventilation related outcomes such as respiratory rate and minute ventilation, but not dyspnea and exercise capacity.

Diaphragmatic breathing (DB), that is also called deep breathing, this breathing is done by contracting the diaphragm, a muscle located horizontally between the thoracic cavity and abdominal cavity. During this type of breathing, air enters in to the lungs, the chest does not rise and belly expands. Diaphragmatic breathing encourages fully oxygen exchange, that is the beneficial trade of incoming oxygen for out going carbon dioxide.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pursed Lip Breathing

Group Type EXPERIMENTAL

Pursed Lip Breathing

Intervention Type OTHER

PLB with frequency of three times daily for First 3 days of week for a duration of 5-10 mins is perform.

Pursed Lip Breathing +DB

Group Type EXPERIMENTAL

Pursed Lip Breathing +DB

Intervention Type OTHER

PLB+DB with frequency of three times daily for Last three days of week for a duration of 10-15 mins is perform.

Conservative care

Group Type EXPERIMENTAL

Conservative care

Intervention Type OTHER

Participants will be having different dose as per tolerance 5 times daily.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pursed Lip Breathing

PLB with frequency of three times daily for First 3 days of week for a duration of 5-10 mins is perform.

Intervention Type OTHER

Pursed Lip Breathing +DB

PLB+DB with frequency of three times daily for Last three days of week for a duration of 10-15 mins is perform.

Intervention Type OTHER

Conservative care

Participants will be having different dose as per tolerance 5 times daily.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants were diagnosed as COPD
* The intervention PLB Combine with DB
* Stable COPD Patients (Mild and Moderate on GOLD criteria) Global Initiative for Chronic Obstructive Lung Disease (GOLD)

Exclusion Criteria

* Patients with other Pulmonary diseases.
* cardiovascular, neurological and orthopedic diseases
* Obesity, history of recent exacerbation
* Uncontrolled arterial hypertension
* Any surgical complications
* Patients with ventilatory support
Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Muhammad Iqbal Tariq, MSCPPT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pulmonology Department of DHQ Teaching Hospital

Dera Ghazi Khan, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/00879 Tayyaba Kanwal

Identifier Type: -

Identifier Source: org_study_id